Purpose Adverse drug reactions (ADRs) are a major patient safety issue, and a substantial proportion of ADRs are, in fact, preventable. The aim of this study was to describe the proportion and pattern of preventable ADRs in spontaneously reported suspected ADRs and to study the feasibility of using data from an ADR reporting system for this purpose. Methods All reports of ADRs, except those in which a vaccine was the suspected drug, submitted to the regional pharmacovigilance center of southeastern Sweden between 2008 and 2009 were analyzed. Causality between the suspected ADR and the medication was assessed using the World Health Organization (WHO) criteria, and preventability was assessed using Hallas criteria. Results During the study period, 1,290 ADRs were received and 1,255 were classified as having at least a possible causality between a reaction and a drug. Of these, 172 (14%) ADRs were considered preventable, 35 (20%) were classified as definitely preventable, and 137 (80%) as possibly preventable. Of all preventable ADRs, 96 (56%) were related to prescribing, 35 (20%) to administration, and 41 (24%) to clinical and laboratory monitoring of treatment. Warfarin, oxycodone, and ioversol were the most common drugs with preventable ADRs.
Introduction
Adverse drug reactions (ADRs) are a major patient safety issue and may have significant consequences to patients and health care systems, both in terms of medical outcome [1] [2] [3] and economic aspects [4, 5] . ADRs occurring as a result of a medication error or substandard care could be considered preventable. The frequencies of preventable ADRs vary considerably in different studies. Most studies [6] [7] [8] [9] [10] indicate that a substantial proportion of ADRs are, in fact, preventable. This seems to be the case also for fatal ADRs [11] . Spontaneous reporting of suspected drug-induced reactions is one of the main sources for detecting drug safety signals of marketed drugs. The strengths of these systems are numerous; they are already an established part of many health care systems, and they monitor all patients and care settings. However, few efforts have been made to use these reports to extract information on how to prevent ADRs [12, 13] . Therefore, this study was undertaken to investigate the proportion and pattern of preventable ADRs by scrutinizing spontaneously reported suspected ADRs and to study the feasibility of using the Swedish ADR reporting system for this purpose.
Methods
In Sweden, healthcare professionals (doctors, nurses, dentists) are requested to report all serious or new suspected ADRs to the Medical Products Agency (MPA). ADRs were defined as all noxious and unintended responses to a medicinal product related to any dose. All reports are sent to one of six regional centers, where information from the reports on the ADR, organ system affected, suspected drug, concomitant medication, age, gender, outcome, and causality are stored in the Swedish Drug Information System (SWEDIS) national database. In each report, there may be more than one drug or ADR reported. Each combination of a drug and a reaction was regarded as one ADR in this study. Classification of drugs are based on the World Health Organization (WHO) Collaborating Center for Drug Statistics Methodology International Anatomical Therapeutic Chemical (ATC) classification [14] . A modified national version of the WHO Adverse Reaction Terminology (WHO-ART) [15] was used to specify the type of reaction for all ADRs; the classification was based on body-system organ classes [16] . In each report, causality was assessed by three experts with particular competence in clinical pharmacology and pharmacovigilance (SH clinical pharmacologist, HL, pharmacist, AKJ, pharmacist) according to established WHO criteria [17] . Reactions were assessed as serious if leading to death, hospitalization, or permanent injury and not serious if the reaction was transient and managed without the need for hospitalization. The preventability assessment was based on previously published criteria by Hallas et al. [18] , here summarized in Table 1 . In brief, each report was assessed by the same panel as for causality. Reports were classified as definitely preventable if use of the drug was not in accordance with good medical practice (e.g., against contraindication, use despite known allergy, lack of compulsory monitoring, etc.) and as possibly preventable if an extra effort would have prevented the occurrence of the ADR (e.g., dose adjustment, vital signs monitoring, etc.). The assessment was based on information assumed to be available to the treating physician at that time and a global evaluation of the narrative provided in the ADR report. If consensus in the expert panel was not reached, the ADR was classified as not preventable. Remaining reports were either classified as not preventable or not evaluable.
After excluding ADRs in which a vaccine was the suspected drug, all remaining reported suspected ADRs submitted to the regional pharmacovigilance center of southeastern Sweden during 2008 and 2009 were scrutinized. Only reports where the causality between a reaction and a suspected drug was assessed as certain, probable, or possible were finally included in the analyses. To the best of our knowledge, there is no validated system for classifying the reason for preventability. We therefore modified a previously used grouping [12] of the reports, classifying preventability as being related to prescribing, administration, or monitoring, as described in Table 2 .
Results
During the study period 7,322 reports (vaccine reports excluded) were submitted to the MPA in Sweden. The regional monitoring center in southeast Sweden received 702 of these reports (9.6%). Health care professionals (doctors, nurses, dentists) working in open-care units submitted 159 reports (23%), and health care professionals working in hospitals submitted 543 reports (77%). The affected patients described in the reports were on average 58 years old (range 0-99). The reports concerned 423 (60%) female patients, 274 (39%) male patients, and information on sex was missing in five cases (1%). In total, 1,290 ADRs were identified, and 1,255 (97%) of these reactions were classified as having at least a possible causality with a suspected drug. Of the 1,255 ADRs, 662 (53%) were classified as serious. Of all ADRs included in the study, 172 (14%) were considered preventable. Of these, 35 (20%) were classified as definitely preventable and 137 (80%) as possibly preventable. Of the definitely preventable ADRs, 24 of 35 (69%) were classified as serious. The corresponding numbers of possibly preventable ADRs were 105 of 137 (77%) ( Table 2 ). Eight of 37 ADRs (22%) classified as contributing to the death of the patient were definitely or possibly preventable. Two ADRs (0.2%) were not evaluable for preventability due to lack of crucial information: in one case, dosage information was missing and in the other, information on laboratory values was missing. Of all preventable ADRs, 96 (56%) were related to prescribing issues, 35 (20%) to drug administration, Table 1 Assessment of preventability of adverse drug reactions (ADRs) [18] Preventability index Description Definitely preventable
The drug event was due to a drug treatment procedure inconsistent with present-day knowledge of good medical practice or was clearly unrealistic, taking the known circumstances into account
Possibly preventable
The prescription was not erroneous but the drug event could have been avoided by an effort exceeding the obligatory demands Not preventable The drug event could not have been avoided by any reasonable means, or it was an unpredictable event in the course of a treatment fully in accordance with good medical practice
Unevaluable
The data for rating could not be obtained or the evidence was conflicting and 41 (24%) to clinical and laboratory treatment monitoring (Table 2 ). In the case of prescription-related preventable ADRs, continuation or reinitiation of treatment despite obvious signs of an ADR, together with lack of doseadjustment when combining with other drugs, were the most common reasons for preventability. Other common reasons for preventability were that relevant precautions such as age were not taken into consideration or that the drug was prescribed despite a known history of allergic reaction. For administration related preventable ADRs, the main reason was erroneous drug administration by the patient. For preventable ADRs relating to suboptimal monitoring, the main reasons were insufficient clinical monitoring (e.g., blood pressure) and insufficient monitoring of, e.g.,
International Normalized Ratio (INR), electrolytes, or liver function markers. Table 3 shows the distribution of included ADRs in relation to ATC classification of the suspected drugs. High numbers of preventable ADRs were found for drugs within the ATC codes N (nervous system, mainly N06 psychoanaleptics and N05 psycholeptics), C (cardiovascular system), B (blood and blood-forming organs, mainly anticoagulants), and A (alimentary tract and metabolism), with 64, 29, 17, and 13 ADRs, respectively. Low numbers of preventable ADRs were noted for ATC codes P (antiparasitic products), R (respiratory system), and S (sensory organs). Warfarin was the most common individual drug with preventable ADRs, followed by oxycodone and ioversol. The drugs with the highest number of preventable ADRs are listed in Table 4 , along with ADR diagnosis.
Discussion
This study showed that in spontaneously reported ADRs in Sweden, 14% was considered preventable, a number that is in accordance with a similar study from France [12] . In that study, which was also based on spontaneously reported ADRs, a frequency of preventable ADRs of 17% was reported. However, in that study, only ADRs resulting from inappropriate prescribing, defined as violation of the recommendations in the drug's Summary of Products Characteristics, were included. Other studies, mainly based on medical-record data and concerning hospitalized patients, reported proportions of preventable ADRs between 19% and 73%, with a median of 35% [10] . As the cases in our study are based on spontaneous reports, which may be influenced by a skewed reporting of reactions, extrapolation to the overall population may be inappropriate.
The prescribing stage has been described as one of the most important in preventing ADR [10, 19] . Accordingly, our study showed that 56% of all preventable ADRs were related to prescribing errors. Continuation or reinitiation of treatment despite obvious signs of ADR is, according to our study, a major point to consider to reduce preventable ADRs. Establishing systems for treatment follow-up and awareness of signs of unwanted reactions is needed to reduce this factor. Increased efforts in pharmacological training, specifically focusing on ADR pharmacology, of nurses and doctors is likely to have beneficial effects. Another factor leading to a high number of preventable ADRs was prescription of drugs without taking relevant precautions into consideration. It is reasonable to believe this factor also could be reduced by educational efforts.
Prescription of a drug despite a known history of allergy to that drug has previously been reported to be a rather common cause of ADRs [20, 21] . In our study, most preventable ADRs related to allergic reactions was reported for contrast diagnostics for X-ray, which is a well-known ADR for this class of drug. These cases could have been prevented if available information of a previous allergic reaction in the medical journal had been observed. Furthermore, in some cases, patients informed the health care personnel about previous allergic reactions retrospectively. Preventing such cases could be based on better notes in medical records and routines or improved pharmacological prevention of reactions. However, the usefulness of pretreatment in unselected patients has been shown to be small [22] . Interestingly, no cases of preventable allergic reactions with anti-infective drugs (ATC J) were reported, despite a large number of reported ADRs of these reactions in conjunction with use of these drugs. This could possibly be explained by a widespread awareness of this class of drug when it comes to allergic reactions, along with routines for documentation and warnings in the medical records. It has been shown that notes in the medical records, despite their lack of validity, influence the choice of antibiotic used [23] .
One factor often discussed in terms of preventable ADRs is drug-drug interactions. In our study, this factor only accounted for 5% of preventable ADRs. Most drug-drug interactions can be handled with dose adjustment or monitoring of laboratory values [24] . Also, there is increasing use of electronic medical records with automatic systems to detect some of these drug interactions that could potentially lead to an ADR. Such systems were available to the majority of the prescribers in the region during the study period. These different forms of clinical decision-support systems has been shown to reduce drug-drug interaction related adverse drug events [25] , possibly explaining the low frequency of interactions as a cause of preventable ADRs in our study.
Preventable ADR relating to drug administration accounted for about 20% of all preventable ADRs. We included erroneous administration by the patient as a cause of preventability, and this was the largest subgroup within administration. One limitation here is that we had incomplete data on, e.g., the patient's cognitive function and to what degree this was accounted for by the prescribing physician. However, we believe that most of these cases could be prevented by better information by health care personnel or pharmacists about the drug and its use. Efforts to reduce errors of administration could include better information to both health care personnel and patients by improved packaging, packet leaflets, and public awareness of drug related safety issues.
Lack of drug treatment monitoring accounted for about 24% of all preventable ADRs. Other studies in the ambulatory setting show that this factor is important, with monitoring accounting for about half (range 22-70%) of preventable ADRs [6] . In our study, many of these cases were related to monitoring of anticoagulant effect during warfarin treatment. Some of these cases included drug interactions with warfarin that is not contraindicated but should have warranted intensive monitoring of INR. It has been shown that drug-drug interactions is a major cause of warfarin bleeding complications and that about 12% of these were preventable through increased monitoring or awareness of interactions [26] . However, in the cases of warfarin interactions, it is important to note that many bleeding complications occur within therapeutic INR range [27] .
As shown in Table 4 , warfarin accounted for 12 preventable ADRs, representing 7% of all preventable ADRs. In the case of warfarin, bleeding and increased INR were the most frequent ADRs that could have been prevented, possibly by increased monitoring, as described above. Anticoagulants have previously been shown to present a high proportion of preventable ADRs [26, 28, 29] , and a study has indicated that warfarin use can also serve as a predictor of preventable ADRs [30] . Oxycodone was the second most frequent drug associated with preventable ADRs. Reactions in these preventable ADRs were dose related, such as respiratory disorders, nausea, and fatigue, which could have been prevented by taking in to account combination with other drugs and increased monitoring of the patient. ADRs resulting from inappropriate or abrupt cessation of treatment were not present in our material.
There was a higher proportion of serious preventable ADRs compared with all reported ADRs. In our set of spontaneously reported cases, eight of 37 ADRs (22%) classified as contributing to the death of the patient were possibly or definitely preventable. Too high a dose, both related to administration and prescription, was the most common reason for preventability in fatal cases. A similar study in a population-based sample of 1,574 deaths in Sweden, selected regardless of cause of death, analyzed cases of fatal ADRs. Three percent of all deaths were considered possibly related to an ADR, and of these, 14% were considered preventable according to the same criteria used in our study [11] .
Some important limitations to our study need to be discussed. The spontaneous reports did not include access to complete medical records, thereby limiting the possibility of extensively describing each case. However, the reports were still useful to analyze preventability. Furthermore, spontaneous reporting of ADRs is, by nature, selective, and only a small proportion of ADRs is reported [31, 32] . It can be anticipated that preventable ADRs, i.e., medication error or substandard care, may be reported in an even lower rate. Definitely preventable ADRs are often due to direct errors or violation of recommendations [33] , and these types of errors are probably reported via ADR systems to an even lower rate. However, the aim of this study was partly to see whether these reports of preventable ADRs actually appear in this established system. Furthermore, our study was limited to three county councils in the southeastern region of Sweden. Regional differences may exist due to different practices and different access to health care institutions, both highly specialized and ambulatory care. A strength of our study is that a panel of experts prospectively performed the assessment. In addition, the use of spontaneous reports allows, in contrast to using medical records, analysis of all kinds of prescriptions and drug-use settings, i.e., primary care, hospital, and emergency settings.
Several different instruments and processes may be used to assess preventability, but there is no established gold standard for this assessment [34] . In this study, we used a definition of preventability [18] based on consensus on whether the treatment was in accordance with present-day good medical practice and whether an extra effort could have prevented the ADR. This method of determining preventability was chosen because it allows a global assessment of the entire treatment situation and excludes no reason for preventability, as could be the case with, e.g., predefined items in a scale. It will also easily allow the addition of preventability analysis to an established system for handling ADRs according to WHO criteria, as is the case in our study.
As with the definition of preventability, there is no widely accepted system for classifying the reason for preventability. Therefore, we set up a number of reasons that appeared in our reports and divided them into subgroups, i.e., prescription, administration, and monitoring. The classification system was related to the objectives of the study. One study focusing on preventable ADRs due to inappropriate prescribing used a slightly different classification system [12] . The drug safety monitoring systems currently in use mainly focus on unsafe drugs rather than the unsafe use of drugs. Finding situations and activities relating to drug treatment and specific drugs where risks of errors occur is an important step toward reducing the harm related to drug use. We believe this study illustrates that it is possible to extract useful information on ADR preventability from spontaneous reporting systems as a mean of identifying suitable interventions to reduce the unsafe use of drugs.
Summary
A substantial portion of reported ADRs was found to be preventable in this study, which indicates that a spontaneous reporting system may be used to identify preventable ADRs, and the reasons thereof, to better understand unsafe use of drugs. Although prescribing, administering, and monitoring medications may all be considered when it comes to planning interventions to reduce ADRs, this study found that preventable ADRs were most commonly related to the prescription of medications. These data indicate that interventions aimed at reducing preventable ADRs should focus on this process.
